December 2025
The global chatbots for mental health and therapy market size is expected to be worth around USD 2.38 billion by 2034 with a CAGR of 5.7% from 2025 to 2035.
September 2026
The global metaverse for mental health market size is expected to hit around USD 24.24 billion by 2035, increasing from USD 3.06 billion in 2026 with a CAGR of 25.91%.
September 2026
The global behavioral and mental health software market size was estimated at USD 8.79 billion in 2026 and is predicted to reach around USD 30.62 billion by 2034, at a CAGR of 16.98%.
September 2026
The mental health clinical trials market size was valued at USD 3.72 billion in 2026 and is projected to surge around USD 7.00 billion by 2034, with a CAGR of 8.24%.
August 2026
The global healthcare chatbots market size was valued at USD 1.49 billion in 2025 and is projected to hit around USD 11.99 billion by 2035 with a CAGR of 23.19%
September 2026
The global salt therapy market size is projected to surpass around USD 20.57 billion by 2035 increasing from USD 9.39 billion in 2026, with a CAGR of 9.12%.
September 2026
The global radioimmunotherapy market size was evaluated at USD 3.65 billion in 2026 and is expected to attain around USD 14.36 billion by 2035, with a CAGR of 16.46%.
August 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The health and wellness market was estimated at USD 5.02 trillion in 2026 and is projected to hit around USD 7.76 trillion by 2035, growing at a CAGR of 4.94%.
September 2026
The global healthcare informatics market size is calculated at USD 52.48 billion in 2026 and is projected to hit around USD 138.09 billion by 2035 with a CAGR of 11.44%.
September 2026
The global health and wellness coaching market size is estimated to hit around USD 37.96 billion by 2034 increasing from USD 21.57 billion in 2026, with a CAGR of 7.32%.
September 2026
The global healthcare information systems market size is projected to hit around USD 1,956.49 billion by 2035 from USD 666.77 billion in 2026 with a CAGR of 12.77%.
September 2026
The health information exchange (HIE) market was valued at USD 2.49 billion in 2026, with leading companies including Cerner Corporation, Allscripts Healthcare Solutions, Inc., McKesson Corporation.
September 2026
The global radioligand therapy market size is estimated to hit around USD 36.47 billion by 2035 increasing from USD 4.08 billion in 2026, with a CAGR of 27.55%.
September 2026
The healthcare workforce management system market size is predicted to surge around USD 5.20 billion by 2034 from USD 2.69 billion in 2026, with a CAGR of 8.59%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global nano healthcare technology for medical equipment market size is estimated to hit around USD 14.63 billion by 2034 from USD 6.61 billion in 2026, with a CAGR of 10.44%
September 2026
The healthcare and life sciences cybersecurity market size stood at USD 31.68 billion in 2026, with major healthcare and life sciences cybersecurity market companies including IBM, Cisco Systems, Palo Alto Networks, Fortinet, CrowdStrike.
September 2026
The global mother and child healthcare market size was evaluated at USD 66.75 billion in 2026 and is predicted to hit around USD 120.67 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The AI for healthcare payer market size reached USD 7.03 billion in 2026, with leading AI for healthcare payer market companies including IBM Watson Health, Optum (UnitedHealth Group), Cigna Corporation, Change Healthcare Inc.
September 2026
The AI in healthcare governance and safety market size stood at USD 2.96 billion in 2026, with major AI in healthcare governance and safety market companies including IBM, Microsoft, Oracle, Google Cloud.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global viral vectors based gene therapy for non-human primates market size is estimated to hit around USD 5.46 billion by 2034 from USD 1.3 billion in 2024, with a CAGR of 15.44%.
September 2026
The global cognitive assessment and brain health market size was evaluated at USD 10.51 billion in 2026 and is predicted to hit around USD 28.69 billion by 2035, growing at a CAGR of 11.80%.
September 2026
The brain health supplements and therapeutics market size was USD 20.42 billion in 2026, with leading brain health supplements and therapeutics market players including Neuriva, Prevagen, Danone, Nestlé Health Science.
September 2026
Healthcare payment integrity is shifting from a predominantly retrospective recovery function toward earlier and more continuous payment-accuracy management. Payers are increasingly using claims editing, coding validation, clinical review, provider analytics, fraud detection, and AI-assisted screening to identify payment issues before or closer to the point of payment. The global healthcare payment integrity market was valued at USD 18.33 billion in 2026 and is projected to reach USD 60.61 billion by 2035 at a CAGR of 14.21%.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
September 2026
The healthcare contract development and manufacturing organization market size reached USD 291.03 billion in 2026, with leading healthcare contract development and manufacturing organization market companies including onza Group Ltd., Covance Inc., Flex.